Navigation Links
Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
Date:1/24/2013

opolysaccharide (LPS) and other factors implicated in the pathogenesis of sepsis.  Perhaps these findings in combination with industry colleague advances will lead to a device that saves the lives of sepsis patients.

Rod's presentation is now accessible online at: http://aethlonmedical.investorroom.com/index.php?s=19.

About Aethlon Medical

Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system.  At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.  For more information, please visit www.aethlonmedical.com.

About The Aethlon Hemopurifier® 

The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system.  In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy.   In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment.  Access to Hemop
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
2. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
3. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
4. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
5. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
6. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
7. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
8. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
11. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Bio-Process Systems Alliance (BPSA) ... Single-Use Summit (ISUS 2015) will be held July ... with a primary focus on the promises and hurdles ... technical topics to business and regulatory presentations, ISUS 2015 ... of the single-use industry as the "go-to" platform in ...
(Date:5/27/2015)... Manitoba , May 27, 2015 ... customers, the Canadian International Pharmacy Association (CIPA) ... medications online from licensed Canadian pharmacies. Approximately 64% of ... maintenance medications from a non-U.S. pharmacy due to ... are not covered under their insurance plan.   ...
(Date:5/27/2015)... May 27, 2015  CytRx Corporation (NASDAQ: CYTR ... oncology, today announced an upcoming poster presentation regarding its ... of Clinical Oncology (ASCO) Annual Meeting, which is being ... Chicago . "I am impressed ... in patients who have undergone treatment with aldoxorubicin across ...
Breaking Medicine Technology:BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
(Date:5/27/2015)... In today's healthcare landscape, where costs are growing ... for doctors and hospitals to keep up with the ... HealthTronics, Inc. is offering a solution to ... clinically sophisticated applications. The company has now broadened its ... Ventures, Inc ., a mobile laser technology company based ...
(Date:5/27/2015)... Dr. Omar Ibrahimi, Dermatologist and Director of the ... selected as part of a controlled launch to be ... physician in Connecticut) to offer the new FDA-cleared ... submental fat (double chin). The procedure is entirely non-invasive, ... minimal risks. Dr. Ibrahimi is an invited faculty trainer ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
(Date:5/27/2015)... 27, 2015 In support of a ... issue of the Journal of American Geriatrics Society about ... obesity, Bedford Commons OB-GYN P.A . is reiterating ... sweetener-flavored beverages. , To examine the relationship between ... San Antonio Longitudinal Study of Aging (SALSA) tracked the ...
(Date:5/27/2015)... Rock, AR (PRWEB) May 27, 2015 ... Medix today announce a partnership to provide CMSA's ... Medix community. This collaboration seeks to strengthen the ... measurement through CMSA’s CKP program. The mutually beneficial ... on identifying individual skills of talent in the ...
Breaking Medicine News(10 mins):Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... amino acid glycine has been shown to be anti-inflammatory ... dietary glycine protected both the lung and liver against ... and improved graft survival after liver transplantation. The influence ... was not known. , A research article to be ...
... a choice of treatment for advanced HCC. CT perfusion ... changes due to TACE therapy for locally advanced HCC. ... this technique in evaluating the efficacy of TACE based ... article published on October 7, 2008 in the ...
... to sign up online at http://www.diabetesatlanta.org , ATLANTA, ... than 600,000 Georgians, could be present in more than,300,000 more, ... disease?, No. The answer is diabetes., And, new ... the U.S. has,nearly doubled in the past 10 years - ...
... for organ donation - where people have to opt out of ... to tackle a growing waiting list for transplant. , That is ... and the illegal trade of body parts, who has recently joined ... are more than 7,500 patients in the UK currently on the ...
... S.C., Oct. 31 InStil Health,Insurance Co., a ... D,prescription drug policies in South Carolina and Georgia, ... been appointed president and,chief operating officer of the ... experience in the health insurance industry,and extensive knowledge ...
... 31 The latest advances in,autism research, treatment ... Conference in Fort Lauderdale. The comprehensive four-day,conference, hosted ... CARE,Clinics, is scheduled for November 13 through 16 ... in Weston, Florida., The conference will feature ...
Cached Medicine News:Health News:As Diabetes Reaches Epidemic Levels in Georgia and U.S., Thousands Drawn to Diabetes University in Atlanta Nov. 8 2Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Jim Hart Named President, COO of InStil Health Insurance Co. 2Health News:National Autism Conference to be Held in Weston, FL November 13-16 2
... Kubtec introduces a breakthrough in specimen radiography. The ... up to 65,536 shades of gray in every ... the smallest changes in density that heretofore were ... digital detectors from 2 x 2 to 8 ...
Commode chair....
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer....
... Multi-Sample Osmometer is designed to automate ... high volumes of samples. By using ... for an accurate determination of total ... the Advanced Instruments Model 3900 will ...
Medicine Products: